Intelligent anti-aging skin care based on independent research     
Lose wrinkles, keep your bank account!     
 
Skin Care 101
Skin Care Basics
Skin Protection
Skin Biology
Biology of Aging
Ingredient Guide
Skin & Nutrition
Skin Conditions
 
Anti-Aging Treatments
Topical Actives
Wrinkle Fillers
Noninvasive
Invasive
 
Skin Care Smarts
Smart Choices
Best Practices
Find Good Skin Doc
Quick Tips
Freebie Finder
 
Reviews & Research
Product Reviews
Provider Reviews
Skin Care Research
Clinical Trials
 
How-To Infopacks
Skin Rejuvenation
DIY Skin Care
Skin & Nutrition
Eye Skin Care
Longevity In a Pill
 
Community & Misc
Forums
Polls & Surveys
News and Updates
Search

-- advertisements --
   
You are here: Skin Care Research >

The use of poly-L-lactic acid in the management of soft-tissue augmentation: a five-year experience.

Author: Vochelle D

Author affiliation: Centre Hospitalier Universitaire de Lille, France Service de Dermatologie, CHU de Lille, France. didiervochelle@tiscali.be

Publication date & source: 2004.12, Semin Cutan Med Surg., 23(4):223-6.

Publication type: Review; Review, Tutorial

Poly-L-lactic acid (PLA) New-Fill* is one of the latest implants commercialized among bioresorbable fillers. This synthetic polymer is biocompatible, biodegradable, immunologically inert, and free from toxicity. All these necessary properties provide theoretical safety. New-Fill* has to be injected deeply into the dermis or into the subcutaneous tissue, so the main indications of New-Fill* are the correction of important wrinkles and furrows from face (Nasolabial folds, "Marionette" lines), and especially spread tissue augmentation for "face modeling" as for cheeks lipoatrophies in HIV patients receiving an antiprotease treatment. After two or three sessions, results are appreciable and equivalent to other resorbable fillers, but seem to last longer. On the other hand, the cost of this material is widely cheaper than others. However, we do not lose sight that the practitioner fee related to a series of two to three sessions of injections compensates for this material economy. Superficial injections should be avoided. They may increase the risk of persistent granulomas, which will be difficult to manage. Even if severe complications are rare, they must be revealed to the patient to obtain his informed consent before injecting.



Indexes of Skin Care Research Abstracts
by Subject Category Most Recent


Google
 
Web SmartSkinCare.com

Home | About Us | Contact Us | Ask a Question | Resources

Copyright © 1999-2008 by Dr. G. Todorov / SmartSkinCare.com
Site Disclaimer | Copyright Certification

   
-- advertisements --